News and Announcements
Actinogen Medical Presenting at the BIO International Conversation in San Diego
- Published June 19, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Actinogen Medical (ASX: ACW) is pleased to announce that the Company‘s CEO, Dr. Bill Ketelbey, is leading the Actinogen team and presenting at the BIO International Convention in San Diego in June 2017. This follows the successful initiation of XanADu, its Phase II trial of Xanamem in Alzheimer’s Disease, and the progress made towards the commencement of a second Phase II trial of Xanamem in Diabetes Cognitive Impairment.
KEY TAKEAWAYS:
- Actinogen Medical presenting at BIO International Convention, the world’s largest and most prestigious biotechnology convention in San Diego, this month.
- BIO International attracts the global biotech industry to network on new opportunities and partnerships.
- Ideal forum to showcase Actinogen Medical and Xanamem, including the successful initiation of our XanADu Alzheimer’s Disease trial and plans to initiate a second Phase II trial of Xanamem in Diabetes Cognitive Impairment.
The BIO International Convention, hosted by the Biotechnology Innovation Organisation (BIO), is the largest global convention for the biotechnology industry and attracts the biggest and best organisations in biotech to network on new opportunities and potential partnerships. Participation at BIO offers Actinogen Medical unparalleled networking opportunities to showcase Xanamem and the quality research that supports its development.
To view the company’s BIO presentation please click the more information button below.